Breast cancer treatment cost in Pyeongtaek

Staging system: TNM (AJCC), commonly grouped as stage 0–IV. Stage is set by tumor size, nodes and spread — it decides which treatment anchors your cost, which is why condition prices span so widely.

• Stage 0 (in situ) Surgery, often with radiation Not yet priced
• Stage I–II (early) Surgery ± radiation; systemic therapy per case Not yet priced
• Stage III (locally advanced) Systemic therapy + surgery + radiation Not yet priced
• Stage IV (metastatic) Ongoing systemic therapy (hormonal, targeted, chemo) Not yet priced

The stage→treatment map is a modeled framework from public clinical taxonomy; prices are this registry's own rows for mapped treatments — empty means we haven't priced it, never a guess. Your stage and pathway are the specialist's call.

Your first spend is the work-up, not the treatment — the typical items, priced from this registry where we hold them.

Consultation fees from our specialist registry; procedure prices from this condition's mapped diagnostics. Unverified prices are labeled on their own pages.

The same care market across the registry — cheapest entry first. Cheapest ≠ best: the MCI column grades each market as its data lands.

• Public-system wait at home (UK)NHS England referral-to-treatment statistics, Apr 2026 · Canada (CIHI) next 11.9-week median
• Recruiting breast cancer trials in South KoreaClinicalTrials.gov — recruiting "breast cancer" studies with a South Korea site · queried 2026-07-09 121 studies
• JCI-accredited organizations in South KoreaJCI public directory, country-wide (all specialties) Not yet sourced

Cheapest entry price per city with the size of its priced treatment menu and specialist density — countable signals only, "—" is never guessed.

Scale of the condition from the global cancer registry — context for why this care market exists.

Having your existing diagnosis re-read here is the cheapest way to test a hospital's quality before booking anything. Prices land per hospital with sources — never estimated.

• Remote records review — written second opinion your existing scans, pathology and reports, reviewed without flying Not yet priced
• Video consultation with a specialist live case discussion after the review Not yet priced
• In-person specialist consultation reference price if you're already here Not yet priced

A second opinion changes the plan often enough that specialists expect to be asked for one — it's a normal request, not an insult. Remote-review prices are being collected per hospital.

How the treatment decision is typically made for this condition — your specialist confirms the path for your case.

1. 1

   See the right specialist

   Care for breast cancer starts with a specialist, who confirms the diagnosis and plans the next steps.

2. 2

   Diagnosis & tests

   The diagnosis is confirmed with Breast Cancer X-ray Screening (Mammogram), Stereotactic Breast Biopsy or Magnetic Resonance Imaging (MRI), which also show how far it has progressed (staging).

3. 3

   Treatment options

   Options include Breast Reconstruction Surgery, Hormonal Therapy (Endocrine Therapy for breast, prostate, thyroid cancers), Hormonal Therapy for Breast Cancer, Reconstructive Surgery (e.g., breast prostheses), Mastectomy, Lumpectomy, Radiation Therapy, Chemotherapy, Targeted Therapy or Immunotherapy — weighed on outcome, downtime, risk and total cost. See the priced menu and decision factors below.

4. 4

   Treatment

   The chosen treatment plan is carried out — every option below links to its own price page with a recovery timeline.

5. 5

   Follow-up & monitoring

   Scheduled scans and check-ups confirm the result and catch any recurrence early; remote follow-up is common for international patients.

Framework pathway modeled by field — per-condition clinical pathways replace it as they're sourced.

Specialist types by pathway phase — never named individuals — with real consultation fees where we hold them. Each links to its own price page.

• Diagnosis Radiologist reads your imaging Fee not yet priced
• Diagnosis Pathologist confirms the diagnosis from the biopsy Fee not yet priced
• Decision & systemic treatment Oncologist stages the disease and owns the treatment plan Fee not yet priced
• Local treatment Radiation therapist plans and delivers radiotherapy Fee not yet priced

Fees are city-level consultation ranges from our specialist registry (imported, re-verified over time). Doctors are hospital attributes — you choose the provider on its hospital page, never a named individual here.

What actually decides between the treatments above — and the checklist an expert would put to the specialist.

A planning frame — suitability is always the specialist's call.

What matters if it goes wrong, and what it takes to get there — country-level, verifiable guidance in one place.

Visa

Most Western nationalities (US, UK, EU/Schengen, Australia, Canada, New Zealand, Japan) enter visa-free for short medical or tourist visits. The K-ETA (electronic travel authorization) requirement is temporarily WAIVED for 67 countries and territories through 31 December 2026 — eligible travellers enter without applying for a K-ETA; the requirement is expected to resume 1 January 2027. Confirm your nationality's current rule before travelling.

Medical / long-stay visa

For treatment, foreign patients typically use the C-3-3 medical tourism visa (short-term, stays up to 90 days, generally not extendable beyond 90 days except in special circumstances). For treatment or recovery longer than 90 days, patients change to or apply for the G-1-10 long-term medical treatment visa, which can be extended inside Korea; it requires hospital documentation (medical opinion, treatment schedule, payment records). Applications must be tied to a medical institution registered with KTO/KHIDI.

Arrival

From 1 January 2026, all foreign arrivals must file the mandatory digital e-Arrival Card online (within 3 days before arrival) — it replaces the paper disembarkation card and is a declaration, not a visa. Travellers who hold an approved K-ETA are exempt from the arrival card, but nationals of K-ETA-waived countries (US, UK, EU, Japan, etc.) must still complete the e-Arrival Card.

Currency

South Korean Won (KRW, ₩)

Languages

Korean; English widely spoken in international-patient centers at major hospitals, with interpreter services in multiple languages

Traveller safety

Very safe for visitors

Legal recourse

Established malpractice recourse

Insurance

Medical-travel & complication cover widely available

International patients

Hospitals accustomed to international patients

General guidance from public sources — confirm current rules for your nationality. Verified against: Korea Immigration — K-ETA temporary exemption extended to 31 Dec 2026 (MOFA/KPMG GMS alert) · Korea e-Arrival Card mandatory from 1 Jan 2026 · Medical Korea — medical visa (C-3-3 / G-1-10), KHIDI · MOHW — Korea attracts 1.17 million foreign patients in 2024.

Who treats breast cancer, and nearby diagnoses in the same field.

Dots carry the lens colors — teal opens a specialist page, red another condition, both priced for Pyeongtaek.

How much of this page is verified data — every section carries a chip telling you where its numbers come from.